Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited
Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 22/11/2010
PIL Sustiva 30 mg/ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to dosage and administration
Updated on 07/05/2010 and displayed until 22/11/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 18/01/2010 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 28/08/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 13/02/2009 and displayed until 28/08/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 17/07/2008 and displayed until 13/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/09/2007 and displayed until 17/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/07/2007 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 31/05/2007 and displayed until 25/07/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/05/2007 and displayed until 31/05/2007
Reasons for adding or updating:
  • Change to side-effects
  • Pending awaiting re-submission
Updated on 26/01/2007 and displayed until 31/05/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
Updated on 07/12/2006 and displayed until 26/01/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 07/02/2006 and displayed until 07/12/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 01/06/2005 and displayed until 07/02/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  efavirenz